Betatrophin and irisin are two novel hormones that have been intensively investigated in recent diabetes treatment research that potentially take part in the mechanisms of T2DM associated with insulin resistance and β cell function. This evidence concerns the gene ANGPTL8 and type 2 diabetes mellitus.